Suppr超能文献

严重肢体缺血的综合治疗及治疗策略

Collective therapy and therapeutic strategy for critical limb ischemia.

作者信息

Masaki Hisao, Tabuchi Atushi, Yunoki Yasuhiro, Kubo Hiroshi, Nishikawa Kosaku, Yakiuchi Hiroki, Tanemoto Kazuo

机构信息

Division of Cardiovascular Surgery, Department of Surgery, Kawasaki Medical School, Kurashiki, Okayama, Japan.

出版信息

Ann Vasc Dis. 2013;6(1):27-32. doi: 10.3400/avd.oa.12.00107. Epub 2013 Feb 15.

Abstract

OBJECTIVE

To determine a treatment strategy based on the outcomes of various previous interventions for critical limb ischemia in arteriosclerosis obliterans (ASO).

MATERIAL AND METHODS

We examined outcomes of 292 ASO patients who had had critical limb ischemia between May 1995 and July 2009. Patients underwent the following procedures in 167 cases: aortofemoral bypass (n = 14), femorofemoral crossover bypass (n = 29), femoropopliteal bypass (n = 104) and femorotibial bypass (n = 40). Other procedures included bypass only (n = 147), bypass combined with thromboendarterectomy (n = 10), bypass combined with endovascular therapy (n = 6), bypass combined with lumbar sympathectomy (n = 2), endovascular therapy combined with thromboendarterectomy (n = 4), endovascular therapy (n = 19), lumbar sympathectomy (n = 6), conservative therapy (n = 65), and major amputation (n = 31). We also calculated P3 risk scores and measured transcutaneous oxygen pressure (tcPO2) and skin perfusion pressure (SPP) before and after therapy.

RESULTS

The limb salvage rate was 87% at 2 years in the arterial reconstruction group. In the low-risk group (a P 3 risk score of 3), the 1-year amputation-free survival rate was 96%. In the medium-risk group (a P 3 risk score of 4-7), the 1-year amputation-free survival rate was 88%. In the high-risk group (a P 3 risk score of 8), the 1-year amputation-free survival rate was 66%. The hospital death rate in the arterial reconstruction group was 3.2%, all of whom were patients who underwent bypass. The survival rate at 5 years was 65% and 36% in the conservative therapy only group. Ulcers healed in 140 out of 144 patients. The 4 patients with unhealed infections had tcPO2 or SPP values of more than 30 mmHg after treatment. Major amputations were performed in 4 of 5 patients who had tcPO2 or SPP values from 20 to 30 mmHg after treatment. Major amputations were performed in all 6 patients who had tcPO2 or SPP values of less than 20 mmHg after treatment.

CONCLUSION

In cases with tcPO2 or SPP values of more than 30 mmHg, an ulcer will probably heal, except in infected cases. We suggest that, if these values are less than 30 mmHg, complete revascularization should be performed. The P3 risk score was useful in predicting limb salvage in the current series. Hybrid therapy in bypass and endovascular therapy must be performed in cases where patients are in a generally poor condition. It is important to attempt amelioration in limb salvage and to control the operative mortality rate with sufficient perioperative control. (English Translation of Jpn J Vasc Surg 2011;20:905-911).

摘要

目的

根据既往对动脉硬化闭塞症(ASO)所致严重肢体缺血的各种干预措施的结果确定一种治疗策略。

材料与方法

我们研究了1995年5月至2009年7月期间292例患有严重肢体缺血的ASO患者的治疗结果。167例患者接受了以下手术:主-股动脉搭桥术(n = 14)、股-股交叉搭桥术(n = 29)、股-腘动脉搭桥术(n = 104)和股-胫动脉搭桥术(n = 40)。其他手术包括单纯搭桥术(n = 147)、搭桥联合血栓内膜切除术(n = 10)、搭桥联合血管内治疗(n = 6)、搭桥联合腰交感神经切除术(n = 2)、血管内治疗联合血栓内膜切除术(n = 4)、血管内治疗(n = 19)、腰交感神经切除术(n = 6)、保守治疗(n = 65)和大截肢术(n = 31)。我们还计算了P3风险评分,并在治疗前后测量了经皮氧分压(tcPO2)和皮肤灌注压(SPP)。

结果

动脉重建组2年时肢体挽救率为87%。在低风险组(P3风险评分为3),1年无截肢生存率为96%。在中风险组(P3风险评分为4 - 7),1年无截肢生存率为88%。在高风险组(P3风险评分为8),1年无截肢生存率为66%。动脉重建组的医院死亡率为3.2%,所有死亡患者均为接受搭桥手术的患者。单纯保守治疗组5年生存率分别为65%和36%。144例患者中有140例溃疡愈合。4例感染未愈合患者治疗后tcPO2或SPP值超过30 mmHg。治疗后tcPO2或SPP值在20至30 mmHg之间的5例患者中有4例接受了大截肢术。治疗后tcPO2或SPP值低于20 mmHg的所有6例患者均接受了大截肢术。

结论

在tcPO2或SPP值超过30 mmHg的病例中,溃疡可能愈合,但感染病例除外。我们建议,如果这些值低于30 mmHg,应进行完全血运重建。在本系列研究中,P3风险评分有助于预测肢体挽救情况。对于全身状况较差的患者,必须采用搭桥和血管内治疗的联合治疗方法。在肢体挽救方面尝试改善并通过充分的围手术期控制来控制手术死亡率非常重要。(《日本血管外科学杂志》2011年英文译文;20:905 - 911)

相似文献

1
Collective therapy and therapeutic strategy for critical limb ischemia.
Ann Vasc Dis. 2013;6(1):27-32. doi: 10.3400/avd.oa.12.00107. Epub 2013 Feb 15.
5
Predictive values of transcutaneous oxygen tension for above-the-ankle amputation in diabetic patients with critical limb ischemia.
Eur J Vasc Endovasc Surg. 2007 Jun;33(6):731-6. doi: 10.1016/j.ejvs.2006.12.027. Epub 2007 Feb 12.
7
Outcomes of dialysis patients with critical limb ischemia after revascularization compared with patients with normal renal function.
J Vasc Surg. 2018 Sep;68(3):822-829.e1. doi: 10.1016/j.jvs.2017.12.048. Epub 2018 Mar 26.
8
Bypass vs. Endovascular Therapy of Infrapopliteal Lesions for Critical Limb Ischemia.
Ann Vasc Dis. 2014;7(3):227-31. doi: 10.3400/avd.oa.14-00070. Epub 2014 Jul 30.

引用本文的文献

2
Utility of Superb Microvascular Imaging in the Assessment of Foot Perfusion in Patients with Critical Limb Ischemia.
Diagnostics (Basel). 2022 Oct 24;12(11):2577. doi: 10.3390/diagnostics12112577.
3
An advanced ultrasound application used to assess peripheral vascular diseases: superb microvascular imaging.
J Echocardiogr. 2021 Sep;19(3):150-157. doi: 10.1007/s12574-021-00527-8. Epub 2021 Apr 15.
5
Limb salvage surgery.
Indian J Plast Surg. 2013 May;46(2):265-74. doi: 10.4103/0970-0358.118603.

本文引用的文献

1
[Role of bypass surgery in crural arterial occlusive lesions].
Nihon Geka Gakkai Zasshi. 2010 Mar;111(2):97-101.
2
Factors associated with death 1 year after lower extremity bypass in Northern New England.
J Vasc Surg. 2010 Jan;51(1):71-8. doi: 10.1016/j.jvs.2009.07.123. Epub 2009 Nov 24.
4
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75. doi: 10.1016/j.ejvs.2006.09.024. Epub 2006 Nov 29.
5
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.
Lancet. 2005 Dec 3;366(9501):1925-34. doi: 10.1016/S0140-6736(05)67704-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验